Key result
Acute coronary syndrome linked to ~8.5-fold higher hs-CRP within 24 hours vs healthy controls.
Why the study?
The study examined the association between high-sensitive C-reactive protein and the lipid profile within 24 hours of symptom onset in patients with ACS.
Are serum high-sensitive C-reactive protein (hs-CRP) and lipid profile levels significantly altered within 24 hours of symptom onset in patients with acute coronary syndrome compared to healthy controls?
Case-Control (n=400)
No
Are serum high-sensitive C-reactive protein (hs-CRP) and lipid profile levels significantly altered within 24 hours of symptom onset in patients with acute coronary syndrome compared to healthy controls?
Early measurement of hs-CRP and lipid profiles within 24 hours of ACS symptom onset demonstrates pronounced inflammatory elevation (particularly after 6 hours) and dyslipidemia, supporting ACC/AHA recommendations for early admission lipid testing to guide statin initiation and risk stratification.
Answers are grounded in this paper and cite their sources.
hs-CRP elevation within 24h was associated with ACS; leaves open its incremental value for early risk stratification in prospective studies.
Aim and objective: The goal of this study was to examine the association of high-sensitive C-reactive protein (hs-CRP) and lipid profile within 24 hours of onset of symptoms in acute coronary syndrome (ACS) patients. Materials and methods:We studied 300 patients with ACS and 100 age-and sex-matched control subjects with no cardiac disease.Acute coronary syndrome patients were classified into two groups (I) onset of ACS symptoms <6 hours and (II) onset of ACS symptoms ≥6 and <24 h.Blood samples were obtained within 24 hours of hospital admission.High-sensitive C-reactive protein and lipid profile were analyzed by latex enhanced immunoturbidimetric method and enzymatic colorimetric methods, respectively.Results: Overall serum levels of hs-CRP at the early phase of ACS were significantly higher (9.15 ± 5.89 vs 1.08 ± 0.7 mg/L, p < 0.001), along with altered lipid profile in patients than in control subjects.In subgroup analysis, serum concentrations of hs-CRP were approximately 3-fold higher in group I when compared with the control group (3.4 ± 2.08 vs 1.08 ± 0.7 mg/L, p < 0.001), and the levels of hs-CRP were almost 12-fold higher in group II than the controls (12.98 ± 4.26 vs 1.08 ± 0.7, p < 0.001).Between ACS patients subgroups, serum hs-CRP levels were almost 4-fold higher in group II when compared with group I (p < 0.001).Conclusions: Our results demonstrate that hs-CRP is significantly higher in the patient's group during the early phase of ACS suggesting that inflammatory processes play a role in ACS.
No takes yet. Share an insight, caveat, or question.
Pandey et al. (2022) conducted a case-control in Acute coronary syndrome (n=400). Early phase of acute coronary syndrome (within 24 hours of symptom onset) vs. Age- and sex-matched healthy control subjects with no cardiac disease was evaluated on Serum high-sensitive C-reactive protein (hs-CRP) levels (mg/L) within 24 hours of symptom onset (p=<0.001). Acute coronary syndrome patients had higher serum hs-CRP levels within 24 hours of symptom onset compared to healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: